HyundaiBio·HyundaiADM First to Identify Penetrium Pseudo Resistance Research Accepted by AACR 신민준 2025.08.29 오후 12:25 Hyundai ADM Hits Limit; NeoImmuneTech Rallies on ARS Survival[K-bio pulse] 김승권 2025.08.29 오전 10:00 Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse] 임정요 2025.07.08 오전 07:59 Hyundai Bioscience vows to license out Korea’s first antiviral 유진희 2025.05.19 오전 09:02 Hyundai Bioscience Initiates Global Phase 2/3 Trial of COVID-19 Treatment Xafty 유진희 2025.05.23 오후 02:08 Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse] 송영두 2025.07.13 오전 09:50 HyundaiBio begins global trials of universal antiviral drug 유진희 2025.04.23 오후 04:28 로딩중..
HyundaiBioscience
HyundaiBioscience
![Hyundai ADM Hits Limit; NeoImmuneTech Rallies on ARS Survival[K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25082900397b.jpg)
![Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25070800251b.jpg)
![Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25071300087b.jpg)
